Prevention of infective complications in systemic lupus erythematosus: A systematic literature review for the APLAR consensus statements. (17th May 2021)

• Record Type: Journal Article
• Authors: Oku, Kenji; Hamijoyo, Laniyati; Kasitanon, Nuntana; Li, Meng Tao; Navarra, Sandra; Morand, Eric; Tanaka, Yoshiya; Mok, Chi Chiu
• Is Part Of: International journal of rheumatic diseases. Volume 24:Number 7(2021)
• Page Start: 880
• Page End: 895
• Publication Date: 2021-05-17
• Subjects: COVID‐19 -- hepatitis B -- hepatitis C -- infection -- lupus -- pneumocystis -- tuberculosis -- vaccine; Rheumatology -- Periodicals; Rheumatology -- Asia -- Periodicals; Rheumatology -- Pacific Area -- Periodicals; Rheumatic Diseases -- Periodicals; Connective Tissue Diseases -- Periodicals; Immune System Diseases -- Periodicals; 616.723
• DOI: 10.1111/1756-185X.14125
• Languages: English
• ISSNs: 1756-1841

Abstract

Abstract: Systemic lupus erythematosus (SLE) is a more common autoimmune rheumatic disease in the Asia‐Pacific region. The prognosis of SLE remains unsatisfactory in some Asian countries because of delayed diagnosis, limited access to medications, increased complications and issues of tolerability and adherence to treatment. The Asia‐Pacific League of Associations for Rheumatology SLE special interest group has recently published a set of consensus recommendations on the management of SLE for specialists, family physicians, specialty nurses, and other healthcare professionals in the Asia‐Pacific region. This article reports a systematic literature review of the infective complications of SLE in Asia and evidence for prevention of these infections by pre‐emptive antimicrobial therapy and vaccination.